FIELD: pharmaceutical industry. SUBSTANCE: pharmaceutical preparation contains misolastin and is characterized by that coated nucleus consisting of retardedrelease misolastin pill associated with fat support and an organic acid. EFFECT: lowered peak concentration in plasma with no loss in bioavailability. 8 cl, 3 dwg, 2 tbl
Authors
Dates
2001-09-27—Published
1997-02-28—Filed